文献速递中毒与环境急症重症综合管理与镇静镇痛

高压氧治疗与一氧化碳中毒死亡率:一项全国性观察性研究

Hyperbaric oxygen therapy and mortality from carbon monoxide poisoning: A nationwide observational study.
PubMed 文献 · Am J Emerg Med · 2019-02-10
一句话结论倾向性评分匹配后,高压氧治疗未显著降低一氧化碳中毒患者院内死亡率,但与出院时意识状态和日常生活活动能力改善显著相关。

该研究利用日本诊断程序组合住院数据库(2010–2016年)纳入成人一氧化碳中毒患者,将入院1天内接受高压氧治疗者(高压氧组,n=2034)与未接受者(对照组,n=4701)进行倾向性评分1:1匹配(2034对)。主要终点院内死亡率在两组间无显著差异(0.8% vs 1.2%,风险差-0.4%,95%CI -1.0至0.2)。高压氧组出院时意识状态抑郁和日常生活活动能力下降的比例显著低于对照组,非重症中毒亚组也显示类似关联。结论认为高压氧虽未显著降低死亡率,但与更好的意识水平和日常生活活动能力显著相关,对非重症中毒患者也可能有益。

要点

  • 倾向性评分匹配后,高压氧组与对照组院内死亡率分别为0.8%和1.2%,风险差-0.4%(95%CI -1.0至0.2),无显著差异。
  • 高压氧组出院时意识状态抑郁和日常生活活动能力下降的比例显著低于对照组。
  • 非重症一氧化碳中毒亚组中,高压氧与出院时意识状态和日常生活活动能力改善的关联与总体结果相似。
  • 高压氧治疗定义为入院1天内接受治疗,对照组为未接受高压氧治疗。
  • 作者结论认为高压氧可能对非重症一氧化碳中毒患者也有益。

适用人群与场景

  • 日本诊断程序组合住院数据库中2010年至2016年登记的成人一氧化碳中毒患者。
  • 纳入对比的人群为入院1天内接受高压氧治疗者(高压氧组)与未接受高压氧治疗者(对照组)。

处置流程与药物剂量

  • 高压氧组定义为入院1天内接受高压氧治疗。

研究设计与关键结果

  • 研究类型为全国性观察性研究,使用日本诊断程序组合住院数据库,纳入成人一氧化碳中毒患者,高压氧组n=2034,对照组n=4701,经1:1倾向性评分匹配形成2034对。
  • 主要终点院内死亡率:高压氧组0.8% vs 对照组1.2%,风险差-0.4%(95%CI -1.0至0.2),无显著差异。
  • 次要终点出院时意识状态抑郁和日常生活活动能力下降:高压氧组比例显著低于对照组。
  • 非重症中毒亚组分析显示与总体相似的关联。

证据类型、等级与局限

  • 证据类型:全国性观察性研究(使用日本诊断程序组合住院数据库),采用倾向性评分匹配。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论认为高压氧治疗虽未显著降低死亡率,但与出院时更好的意识水平和日常生活活动能力显著相关,作者认为对非重症一氧化碳中毒患者也可能有益。
  • 原文未据此给出关于高压氧治疗用于降低死亡率的推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The effects of hyperbaric oxygen therapy (HBOT) on mortality or morbidity in patients with carbon monoxide (CO) poisoning remain unknown. We examined the effects of HBOT on CO poisoning and further strived to delineate its inherent effects on specific subgroups of patients using a nationwide inpatient database.

METHODS: We identified adult patients with CO poisoning who were registered in the Japanese Diagnosis Procedure Combination inpatient database from 2010 to 2016. Propensity score-matching was performed to compare patients who received HBOT within 1 day of admission (HBOT group) with those who did not receive HBOT (control group). The primary outcome was in-hospital mortality. The secondary outcomes were a depressed mental status and reduced activities of daily living (ADL) at discharge. We also performed subgroup analyses divided according to severity of CO poisoning.

RESULTS: Eligible patients were categorized into the HBOT group (n = 2034) or the control group (n = 4701). One-to-one propensity score-matching created 2034 pairs. In-hospital mortality was not significantly different between the HBOT and control groups (0.8% vs. 1.2%, risk difference: -0.4%, 95% confidence interval: -1.0 to 0.2). Patients in the HBOT group had significantly lower proportions of a depressed mental status and reduced ADL at discharge than did those in the control group. Similar associations were shown in the non-severe poisoning subgroup.

CONCLUSIONS: Although HBOT was not significantly associated with reduced mortality, it was significantly associated with a favorable consciousness level and ADL in patients with CO poisoning. HBOT may be beneficial even for patients with non-severe CO poisoning.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Nakajima M, Aso S, Matsui H, et al. Hyperbaric oxygen therapy and mortality from carbon monoxide poisoning: A nationwide observational study. Am J Emerg Med. 2019. PMID: 30797609. doi:10.1016/j.ajem.2019.02.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。